While trained to save the lives of the critically ill, these physicians must also have the skills and knowledge to provide palliative care to the patient and emotional support for the family when end of life is inevitable.

Sleep is increasingly recognized as an important contributor to health, yet many Americans regularly do not get enough sleep. To learn if inadequate sleep increases their risks of heart disease, NYP Columbia study the relationship between sleep habits and cardiovascular risk factors.

Despite years of investigations, the origin of idiopathic pulmonary fibrosis has remained elusive. Researchers at NewYork-Presbyterian/Weill Cornell are looking into new therapies to slow the progression.

The pediatric oncology program at NewYork-Presbyterian/Columbia is one of the front-runners nationally instituting and implementing real-time precision oncology for patients, including the establishment in 2014 of a precision-in-pediatric sequencing program called the PIPseq Cancer Program.

Chimeric antigen receptor (CAR) T-cell therapy engages an individual’s own immune cells to treat cancer, and, in particular, hematological malignancies.

See what our specialists say about gene therapy's role in the treatment of thalassemia and hemophilia.

In a quest to better define depression diagnosis, a neuroscientist and psychiatrist at NewYork-Presbyterian/Weill Cornell used fMRI brain scans to identify unique subtypes of depression.

Dr. Mann and his Columbia colleagues have been investigating the use of ketamine as a treatment option for rapidly reducing suicidal thoughts in patients with refractory depression.